Page last updated: 2024-08-21

8-aminoquinoline and Kidney Diseases

8-aminoquinoline has been researched along with Kidney Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berman, J; Brewer, T; Carvalho, SF; Dietze, R; Grogl, M; Milhous, W; Sanchez, J; Schuster, B; Valli, LC	1

Trials

1 trial(s) available for 8-aminoquinoline and Kidney Diseases

Article	Year
Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi. The American journal of tropical medicine and hygiene, 2001, Volume: 65, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Animals; Antiprotozoal Agents; Child; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; Leishmania; Leishmaniasis, Visceral; Male; Middle Aged; Treatment Outcome	2001

Article

Year

Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi.

The American journal of tropical medicine and hygiene, 2001, Volume: 65, Issue:6

Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Animals; Antiprotozoal Agents; Child; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; Leishmania; Leishmaniasis, Visceral; Male; Middle Aged; Treatment Outcome

2001